(Date:12/4/2009)... Vivakor, Inc. (OTC Bull...lders of record on December 1, 2009 will receive t...rica, Inc. that was previously approved by Vivakor... Nevada corporation of which Vivakor owned approxi... record date. The distribution date is still expec...
(Date:12/4/2009)...anced Micro Nano Technology Products (ACAMP) hosts..., Dec. 4 /PRNewswire/ - Today ACAMP hosted a healt...es like nanotechnology, biomaterials and microflui...nnovative healthcare products that help promote he... patient care, while opening new markets for Alber...
(Date:12/4/2009)...swire/ -- Stemline Therapeutics, Inc. today announ...3R targeting agents, SL-401 and SL-501, in both i...d leukemia (CML) have been selected for poster pre...he American Society of Hematology (ASH), to be hel...er will be presented by Stemline,s collaborators a...
(Date:12/4/2009)...PRNewswire-FirstCall/ -- BlueFire Ethanol Fuels, I...on changing the world,s transportation fuel paradi... cellulosic wastes, has been ranked number 19 on t...nies in Bioenergy;" the company,s second consecuti...BlueFire Ethanol among the top 20 bioenergy compan...
Breaking Biology Technology:Vivakor Confirms Record Date of Stock Dividend 2Vivakor Confirms Record Date of Stock Dividend 3Alberta companies delivering new products to the health & medical marketplace 2Stemline Therapeutics Announces Poster Presenting in vivo and Anti-Cancer Stem Cell Activity of SL-401 against Chronic Myeloid Leukemia (CML) at the 51st Annual Meeting of the American Society of Hematology (ASH) 2BlueFire Named One of Top 20 Bioenergy Companies for Second Consecutive Year 2BlueFire Named One of Top 20 Bioenergy Companies for Second Consecutive Year 3BlueFire Named One of Top 20 Bioenergy Companies for Second Consecutive Year 4...in Board: AGGX.OB) a New York-based biotechnology ...d anti-angiogenic drugs, announced the,appointment.... Dr. Garland,formerly with Hoffmann La Roche, Inc...for a number of early stage biotech companies such..., Lpath Therapeutics, Inc.,(LPTN.OB) and Tosk in a...
...fe, Inc. (NYSE: CRY ), and BioForm Medical, Inc. ...ceived a CE Mark for the use of CryoLife,s,BioGlue...ng endoscopic,browplasty or brow lift, a reconstru...val allows the product to be marketed in the Europ...by CryoLife,s partner BioForm Medical, for,use in ...
...nics Corporation,s (Amex: ETC ) ("ETC" or the "Co...d the sale of seven (7) BARA-MED(R) XD,Monoplace H...t at four (4),facilities associated with Haelen Hy...Hyperbarics, a growing network of,physician operat...n,Hyperbarics also provides physicians with turn-k...
Other Biology Technology:AngioGenex Appoints New CEO to Direct Development of Anti-Cancer Drugs 2AngioGenex Appoints New CEO to Direct Development of Anti-Cancer Drugs 3CryoLife's BioGlue(R) Surgical Adhesive Receives European Approval for use in Browlift Cosmetic and Reconstructive Plastic Surgery 2CryoLife's BioGlue(R) Surgical Adhesive Receives European Approval for use in Browlift Cosmetic and Reconstructive Plastic Surgery 3CryoLife's BioGlue(R) Surgical Adhesive Receives European Approval for use in Browlift Cosmetic and Reconstructive Plastic Surgery 4Environmental Tectonics Corporation's BioMedical Systems Division Awarded Contract for Multiple Monoplace Chambers 2Environmental Tectonics Corporation's BioMedical Systems Division Awarded Contract for Multiple Monoplace Chambers 3Anti-JIP 1 / 2 (SH3) Polyclonal Antibody, Unconjugated, Clone ZMD.177 from Invitrogen
Mouse Anti-G-alpha-i 1 G-Protein Monoclonal Antibody, Unconjugated from AnaSpec
Rabbit Anti-oligophrenin-1 Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
Mouse Anti-DAP Kinase 1 Monoclonal Antibody, Unconjugated, Clone DAPK-55 from Abcam
Biology Products: